Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study.
about
Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesChlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology.Antibiotics in the prevention and treatment of coronary heart disease.Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography.Weighing the evidence for infection as a risk factor for coronary heart disease.Potential infectious etiologies of atherosclerosis: a multifactorial perspectiveChronic infections and atherosclerosis/thrombosis.Association of cardiac ausculatory findings with coronary heart disease mortality.Chlamydophila pneumoniae infection and cardiovascular diseaseIndividual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.Endobiogeny: a global approach to systems biology (part 1 of 2).Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.Chlamydia pneumoniae and progression of subclinical atherosclerosis.Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran.Preeclampsia and Chlamydia pneumoniae: is there a link?Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay.Description and status of the azithromycin and coronary events study (ACES).Lycopene Inhibits Propagation of Chlamydia Infection.Relationship of classical and non-classical risk factors with genetic variants relevant to coronary heart disease
P2860
Q33905858-0C073D32-A06B-40A2-A0AD-69473B2EDDDDQ33935019-99BA6A87-B63C-4BD2-AD96-42AD1091FCB1Q33935098-2C5C8640-0EA8-46C5-8CEF-63E9DB945DF0Q33971224-D5DF9B3C-9E36-47C1-91A7-A856BA4DE4EBQ34011168-B5AFDC04-A48B-4026-BFC4-5EBC02547B04Q34465370-627D1A94-FB5C-4784-AFD1-B8B72BE7E3B0Q34514051-7F39FA6A-BDD3-4D80-B6B1-121A8E63428BQ35999916-E9C6129F-4C7A-4928-AFD5-5E4442A6F772Q36783331-5127F5C2-31C6-49D7-95BF-36A0C129A1E6Q37320829-DA51C0B2-6CB4-4116-8E3D-0C8348901A59Q37324095-85925848-B896-4CC5-8D43-9733CD00D2E5Q37346172-8FDA6597-B10E-4E6D-B9B1-A883D87CCBC3Q37847433-8E21B79A-39D0-4809-A9EF-DCFF44445709Q37865613-C8064DB1-6AC2-4A05-B4E1-7AFA1CD303F1Q37866465-8C9A6574-2156-4273-996D-57828C77A795Q37872308-7F14F2E7-454D-4C8B-9E14-7B195A61B0D6Q37876308-36082F3B-3710-4143-AE76-F332B0E38EEAQ41694991-AD59D67B-D3FD-4BC7-8C2B-3E9864CBEB16Q57235917-E753122D-2F01-4937-BC0D-F40E9C88CE4A
P2860
Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@en
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@nl
type
label
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@en
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@nl
prefLabel
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@en
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@nl
P2093
P1476
Chlamydia pneumoniae infection ...... sis Risk in Communities Study.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.AJE.A009974
P407
P577
1999-07-01T00:00:00Z